117 related articles for article (PubMed ID: 2905248)
1. Pharmacokinetics of roxatidine in healthy volunteers.
Collins JD; Pidgen AW
Drugs; 1988; 35 Suppl 3():41-7. PubMed ID: 2905248
[TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic characteristics of roxatidine.
Bender W; Brockmeier D
J Clin Gastroenterol; 1989; 11 Suppl 1():S6-19. PubMed ID: 2572622
[TBL] [Abstract][Full Text] [Related]
4. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
Chen WW; Kolsky H; Lewin MJ; Bonfils S
Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the H(2) blocker roxatidine acetate hydrochloride in pediatric patients, in comparison with healthy adult volunteers.
Nakamura H; Kawashima H; Azuma R; Sato I; Nagao K; Miyazawa K
Drug Metab Pharmacokinet; 2012; 27(4):422-9. PubMed ID: 22293541
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of roxatidine acetate in patients with chronic liver disease.
Tsutsumi M; Ueshima Y; Takase S
J Gastroenterol Hepatol; 2001 Aug; 16(8):910-5. PubMed ID: 11555106
[TBL] [Abstract][Full Text] [Related]
7. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
Hemery P; Congard P; Galmiche JP; Bonfils S
Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
[TBL] [Abstract][Full Text] [Related]
8. Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection.
Burrows JL; Jolley KW; Sullivan DJ
J Chromatogr; 1988 Nov; 432():199-208. PubMed ID: 2906063
[TBL] [Abstract][Full Text] [Related]
9. Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders.
Murdoch D; McTavish D
Drugs; 1991 Aug; 42(2):240-60. PubMed ID: 1717223
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic study of roxatidine acetate in chronic renal failure.
Lameire N; Rosenkranz B; Maass L; Brockmeier D
Drugs; 1988; 35 Suppl 3():48-52. PubMed ID: 2905249
[TBL] [Abstract][Full Text] [Related]
11. Interaction of roxatidine acetate with antacids, food and other drugs.
Labs RA
Drugs; 1988; 35 Suppl 3():82-9. PubMed ID: 2905254
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
Gladziwa U; Wagner S; Sieberth HG; Klotz U
Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
[TBL] [Abstract][Full Text] [Related]
13. Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers.
Huang SM; Marriott TB; Weintraub HS; Arnold JD; Boccagno J; Abels R; Harris W
Eur J Clin Pharmacol; 1988; 34(1):101-4. PubMed ID: 2896125
[TBL] [Abstract][Full Text] [Related]
14. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates.
Tanaka E; Nakamura K
Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603
[TBL] [Abstract][Full Text] [Related]
15. A review of the animal pharmacology of roxatidine acetate.
Scholtholt J; Bickel M; Herling AW
Drugs; 1988; 35 Suppl 3():30-40. PubMed ID: 2905247
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of multiple dose sucralfate on the pharmacokinetics of of roxatidine acetate.
Seibert-Grafe M; Pidgen A
Eur J Clin Pharmacol; 1991; 40(6):637-8. PubMed ID: 1679394
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure.
Lameire N; Rosenkranz B; Brockmeier D
Scand J Gastroenterol Suppl; 1988; 146():100-10. PubMed ID: 2906455
[TBL] [Abstract][Full Text] [Related]
18. Penetration of roxatidine into the cerebrospinal fluid.
Tryba M; Kurz-Muller K
Scand J Gastroenterol Suppl; 1988; 146():153-8. PubMed ID: 2906459
[TBL] [Abstract][Full Text] [Related]
19. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
